Form 4 for AORT ARTIVION, INC.

Accepted 2022-02-10 00:00:00 ET · period of report 2022-02-08 · accession 0000784199-22-000018 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-02-10	2022-02-08	AORT	Mackin James P	Pres, CEO	M - OptEx	$11.00	+10.6K	314.8K	+3%	+$117.0K
D	2022-02-10	2022-02-08	AORT	Mackin James P	Pres, CEO	S - Sale+OE	$17.75	-10.6K	304.2K	-3%	-$188.8K
D	2022-02-10	2022-02-08	AORT	Mackin James P	Pres, CEO	M - OptEx	$11.00	-10.6K	21.3K	-33%	-$117.0K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-02-08	M	A	10,638	$11.00	314,816	D	—	—	(F1) The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Sept 3, 2021
2	Common	Common Stock	2022-02-08	S	D	10,638	$17.75	304,178	D	—	—	(F1) The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Sept 3, 2021 (F2) Reflects weighted average price. Range of prices were between $17.4 to $17.89. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
3	Derivative	StockOption(RightTo Buy)	2022-02-08	M	D	10,638	$11.00	21,277	D	$11.00 · 2016-02-19 to 2022-02-19	10,638 Common Stock	(F3) Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2016